Biorelevant release testing

• Using tissue simulating hydrogel compartments
• Simulating physiological flow and / or movement
• Using 3D-printing technologies to develop new / adapted apparatuses
• Currently for implants and injections such as ophthalmologic dosage forms, cardiovascular implants, dosage forms for intramuscular and subcutaneous delivery, etc.

Development of dosage forms using 3D-printing

• Production of drug-containing filaments for fdm-based printing
• Printing of implants and oral dosage forms via fdm
• Characterization of the printed dosage forms
• Individualization
• Influencing drug release